Masimo Corporation (NASDAQ:MASI) insider Rick Fishel sold 15,000 shares of the stock in a transaction dated Tuesday, July 11th. The stock was sold at an average price of $92.85, for a total value of $1,392,750.00. Following the sale, the insider now directly owns 35,022 shares in the company, valued at $3,251,792.70. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.
Rick Fishel also recently made the following trade(s):
- On Friday, July 14th, Rick Fishel sold 15,000 shares of Masimo Corporation stock. The shares were sold at an average price of $94.85, for a total value of $1,422,750.00.
Masimo Corporation (MASI) opened at 85.39 on Wednesday. The firm has a 50-day moving average of $93.48 and a 200-day moving average of $89.40. The stock has a market capitalization of $4.44 billion, a price-to-earnings ratio of 14.00 and a beta of 0.80. Masimo Corporation has a 1-year low of $53.78 and a 1-year high of $104.71.
Masimo Corporation (NASDAQ:MASI) last announced its earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a net margin of 45.90% and a return on equity of 23.45%. The firm had revenue of $192.90 million for the quarter, compared to analyst estimates of $189.03 million. During the same quarter last year, the business earned $0.57 earnings per share. Masimo Corporation’s revenue was up 11.8% compared to the same quarter last year. Equities research analysts anticipate that Masimo Corporation will post $2.80 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This story was published by BBNS and is the sole property of of BBNS. If you are accessing this story on another publication, it was copied illegally and reposted in violation of US and international copyright and trademark law. The correct version of this story can be accessed at https://baseballnewssource.com/markets/masimo-corporation-masi-insider-rick-fishel-sells-15000-shares-updated-updated-updated/1198315.html.
A number of equities research analysts have recently commented on the company. Wedbush restated an “outperform” rating and set a $112.00 target price on shares of Masimo Corporation in a research report on Monday, May 22nd. Stifel Nicolaus started coverage on Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 price objective on the stock. BidaskClub upgraded Masimo Corporation from a “hold” rating to a “buy” rating in a report on Wednesday, July 12th. Roth Capital lifted their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a report on Wednesday, July 19th. Finally, Zacks Investment Research cut Masimo Corporation from a “hold” rating to a “sell” rating in a report on Tuesday, July 4th. Five analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of $94.00.
Institutional investors have recently bought and sold shares of the company. Meritage Portfolio Management bought a new position in Masimo Corporation during the first quarter worth $5,109,000. Acadian Asset Management LLC increased its position in shares of Masimo Corporation by 45.0% in the first quarter. Acadian Asset Management LLC now owns 1,399,187 shares of the medical equipment provider’s stock worth $130,489,000 after buying an additional 434,389 shares in the last quarter. ProShare Advisors LLC raised its stake in Masimo Corporation by 11.5% in the first quarter. ProShare Advisors LLC now owns 8,418 shares of the medical equipment provider’s stock worth $785,000 after buying an additional 870 shares during the last quarter. Personal Capital Advisors Corp purchased a new stake in Masimo Corporation during the first quarter worth $234,000. Finally, Nationwide Fund Advisors raised its stake in Masimo Corporation by 25.8% in the first quarter. Nationwide Fund Advisors now owns 324,526 shares of the medical equipment provider’s stock worth $30,265,000 after buying an additional 66,524 shares during the last quarter. 84.39% of the stock is currently owned by institutional investors.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with our FREE daily email newsletter.